Travere Therapeutics (TVTX) PT Raised to $60 at TD Cowen
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $55.11 -0.07%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $60.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Travere Therapeutics (TVTX) PT Raised to $61 at Wedbush
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
